DK293088D0 - Inhibitorer af dopamin-beta-hydroxylase - Google Patents

Inhibitorer af dopamin-beta-hydroxylase

Info

Publication number
DK293088D0
DK293088D0 DK293088A DK293088A DK293088D0 DK 293088 D0 DK293088 D0 DK 293088D0 DK 293088 A DK293088 A DK 293088A DK 293088 A DK293088 A DK 293088A DK 293088 D0 DK293088 D0 DK 293088D0
Authority
DK
Denmark
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
DK293088A
Other languages
English (en)
Other versions
DK293088A (da
Inventor
Joseph Alan Finkelstein
Lawrence Ivan Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK293088D0 publication Critical patent/DK293088D0/da
Publication of DK293088A publication Critical patent/DK293088A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK293088A 1987-06-01 1988-05-27 Inhibitorer af dopamin-beta-hydroxylase DK293088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/056,018 US4835154A (en) 1987-06-01 1987-06-01 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors

Publications (2)

Publication Number Publication Date
DK293088D0 true DK293088D0 (da) 1988-05-27
DK293088A DK293088A (da) 1988-12-02

Family

ID=22001632

Family Applications (1)

Application Number Title Priority Date Filing Date
DK293088A DK293088A (da) 1987-06-01 1988-05-27 Inhibitorer af dopamin-beta-hydroxylase

Country Status (7)

Country Link
US (1) US4835154A (da)
EP (1) EP0294973A1 (da)
JP (1) JPS63310872A (da)
AU (1) AU1644788A (da)
DK (1) DK293088A (da)
PT (1) PT87642B (da)
ZA (1) ZA883851B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
CA2018438C (en) * 1989-06-14 2000-08-08 Joseph Alan Finkelstein Imidazolyl-alkenoic acids
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
US5135944A (en) * 1989-06-21 1992-08-04 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure
US5100912A (en) * 1990-05-14 1992-03-31 Syntex (U.S.A.) Inc. Bis(benzylpyrrolidine) derivatives as dopamine agonists
US5093355A (en) * 1989-10-30 1992-03-03 Syntex (U.S.A.) Inc. Benzylpyrrolidine derivatives as dopamine agonists
EP0921801A1 (en) * 1996-04-03 1999-06-16 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2250587A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
US5972942A (en) * 1997-03-27 1999-10-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2000086583A (ja) * 1998-09-17 2000-03-28 Asahi Glass Co Ltd 含フッ素ベンジル誘導体の製造方法
SK11002001A3 (sk) * 1999-02-11 2002-05-09 Pfizer Products Inc. Heteroarylom substituované chinolin-2-ónové deriváty použiteľné ako protinádorové prostriedky
WO2004069809A1 (en) * 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
EP3971178A1 (en) 2012-03-07 2022-03-23 The McLean Hospital Corporation Aminoquinoline derivatives and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131192C (da) * 1965-06-16
US4022783A (en) * 1975-10-29 1977-05-10 Usv Pharmaceutical Corporation Piperazinyl-imidazolines
IT1159698B (it) * 1978-05-29 1987-03-04 Rotta Research Lab Derivati 5-nitro-imidazolici della piperazina ad attivita' antiprotozoica
US4338453A (en) * 1980-09-17 1982-07-06 The Upjohn Company Aminoalkyl-1,2,4-triazoles
JPS57106663A (en) * 1980-12-23 1982-07-02 Kyorin Pharmaceut Co Ltd 1,4-disubstituted piperazine derivative and its preparation
US4487761A (en) * 1982-04-05 1984-12-11 Merck & Co., Inc. Dopamine β-hydroxylase inhibitors
DE3217094A1 (de) * 1982-05-07 1983-11-10 Hoechst Ag, 6230 Frankfurt 1-substituierte imidazol-5-carbonsaeurederivate, ihre herstellung sowie ihre verwendung als biozide
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4719223A (en) * 1985-10-31 1988-01-12 Smithkline Beckman Corporation Imidazolethiol dopamine-beta-hydroxylase inhibitors
US4743613A (en) * 1986-04-08 1988-05-10 Smithkline Beckman Corporation Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
NZ221427A (en) * 1986-08-18 1990-12-21 Smithkline Beckman Corp 2-mercaptoimidazole derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
PT87642A (pt) 1988-07-01
DK293088A (da) 1988-12-02
AU1644788A (en) 1988-12-01
JPS63310872A (ja) 1988-12-19
EP0294973A1 (en) 1988-12-14
PT87642B (pt) 1992-09-30
ZA883851B (en) 1989-04-26
US4835154A (en) 1989-05-30

Similar Documents

Publication Publication Date Title
DK598488D0 (da) Taageeliminatorapparat af underkoelingstypen
KR890013569U (ko) 클립
DE3890290T1 (de) Verbaende
ATE97652T1 (de) Peptidasehemmungsmittel.
ES2025067B3 (es) Barril
DK293088D0 (da) Inhibitorer af dopamin-beta-hydroxylase
FI101796B1 (fi) Uusia -glukosidaasi-inhibiittoreita
DE69117544D1 (de) Gewindeschneideinsatz
DK163088D0 (da) Dopamin-beta-hydroxylase inhibitor
DK440887A (da) Dopamin-beta-hydroxylase-inhibitorer
DK174087A (da) Angiotensinkonverterende enzyminhibitor
DK440989A (da) Dopamin-beta-hydroxylase inhibitorer
DK562289D0 (da) Anvendelse af somatostatiner
DK69489A (da) Aspartattranscarbamylase-inhibitorer
DK570688D0 (da) Fremgangsmaade til rensning af polyorganphosphanzenelastromerer
DK318383D0 (da) Urtepotte
DK178788D0 (da) Inhibitorer af dopamin-beta-hydroxylase
NO872985L (no) Inhibitor for polyuretanpropergoler.
KR890002480U (ko) 클립
DK279488A (da) Fremgangsmaade til diagnosticering af aids
NO881638D0 (no) Dopamin-beta-hydroksylase-inhibitorer.
KR890002990U (ko) 관계수
IT8733315V0 (it) Graffetta
SE8704438D0 (sv) Plattformsvag t ex badrumsvag
SE8702229D0 (sv) New use ii

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment